SOLENO THERAPEUT. DL-001 (6XC) — Cash Flow Quality Index

Latest as of December 2025: 1.12x

SOLENO THERAPEUT. DL-001 (6XC) has a Cash Flow Quality Index of 1.12x as of December 2025. Operating cash flow of €48.70 Million exceeds net income of €43.36 Million, indicating high earnings quality where cash backs reported profits. Explore 6XC long-term investment intensity to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

1.12x
Operating CF / Net Income

Operating Cash Flow

€48.70 Million
EUR

Net Income

€43.36 Million
EUR

Data as of

Dec 2025
Most recent filing

SOLENO THERAPEUT. DL-001 Cash Flow Quality Index (2025–2025)

Historical Cash Flow Quality Index for SOLENO THERAPEUT. DL-001 across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 6XC tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Annual Cash Flow Quality Index for SOLENO THERAPEUT. DL-001 (2025–2025)

Year-by-year earnings quality comparison for SOLENO THERAPEUT. DL-001. For live market cap and the full company financial profile, see 6XC market cap overview.

Year Quality Index Operating CF (EUR) Net Income YoY Change
2025 2.24x €46.80 Million €20.89 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.